Diagnosing and managing oropharyngeal candidiasis

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Oropharyngeal candidiasis (OPC) is often one of the first signs of immunodeficiency. The symptoms may include a sore and painful mouth, a burning tongue, dysgeusia, and dysphagia. However, some patients are asymptomatic despite the presence of clinical signs, such as diffuse erythema and whitish patches on the surfaces of the buccal mucosa, throat, tongue, and gums. The most serious complication of untreated OPC is extension of infection into the esophagus. Although numerous antifungal agents are available, the azoles - both topical (clotrimazole) and systemic (fluconazole, itraconazole, posaconazole) - have replaced older topical antifungals in the management of OPC. Fluconazole has become an integral part of the management of mucosal candidiasis. Itraconazole and posaconazole have clinical response rates similar to those of fluconazole and are effective alternatives.

Original languageEnglish (US)
Pages (from-to)427-436
Number of pages10
JournalInfections in Medicine
Volume24
Issue number10
StatePublished - Oct 1 2007

Fingerprint

Candidiasis
Fluconazole
Itraconazole
Tongue
Dysgeusia
Clotrimazole
Azoles
Antifungal Agents
Mouth Mucosa
Gingiva
Erythema
Deglutition Disorders
Pharynx
Esophagus
Mouth
Infection
posaconazole

Keywords

  • Antifungal agents
  • Azoles
  • Oropharyngeal candidiasis

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Diagnosing and managing oropharyngeal candidiasis. / Vazquez, Jose A.

In: Infections in Medicine, Vol. 24, No. 10, 01.10.2007, p. 427-436.

Research output: Contribution to journalArticle

@article{f0cd745a10ff44a8bbd203917bbf94b1,
title = "Diagnosing and managing oropharyngeal candidiasis",
abstract = "Oropharyngeal candidiasis (OPC) is often one of the first signs of immunodeficiency. The symptoms may include a sore and painful mouth, a burning tongue, dysgeusia, and dysphagia. However, some patients are asymptomatic despite the presence of clinical signs, such as diffuse erythema and whitish patches on the surfaces of the buccal mucosa, throat, tongue, and gums. The most serious complication of untreated OPC is extension of infection into the esophagus. Although numerous antifungal agents are available, the azoles - both topical (clotrimazole) and systemic (fluconazole, itraconazole, posaconazole) - have replaced older topical antifungals in the management of OPC. Fluconazole has become an integral part of the management of mucosal candidiasis. Itraconazole and posaconazole have clinical response rates similar to those of fluconazole and are effective alternatives.",
keywords = "Antifungal agents, Azoles, Oropharyngeal candidiasis",
author = "Vazquez, {Jose A.}",
year = "2007",
month = "10",
day = "1",
language = "English (US)",
volume = "24",
pages = "427--436",
journal = "Infections in Medicine",
issn = "0749-6524",
publisher = "CMP Healthcare Media LLC",
number = "10",

}

TY - JOUR

T1 - Diagnosing and managing oropharyngeal candidiasis

AU - Vazquez, Jose A.

PY - 2007/10/1

Y1 - 2007/10/1

N2 - Oropharyngeal candidiasis (OPC) is often one of the first signs of immunodeficiency. The symptoms may include a sore and painful mouth, a burning tongue, dysgeusia, and dysphagia. However, some patients are asymptomatic despite the presence of clinical signs, such as diffuse erythema and whitish patches on the surfaces of the buccal mucosa, throat, tongue, and gums. The most serious complication of untreated OPC is extension of infection into the esophagus. Although numerous antifungal agents are available, the azoles - both topical (clotrimazole) and systemic (fluconazole, itraconazole, posaconazole) - have replaced older topical antifungals in the management of OPC. Fluconazole has become an integral part of the management of mucosal candidiasis. Itraconazole and posaconazole have clinical response rates similar to those of fluconazole and are effective alternatives.

AB - Oropharyngeal candidiasis (OPC) is often one of the first signs of immunodeficiency. The symptoms may include a sore and painful mouth, a burning tongue, dysgeusia, and dysphagia. However, some patients are asymptomatic despite the presence of clinical signs, such as diffuse erythema and whitish patches on the surfaces of the buccal mucosa, throat, tongue, and gums. The most serious complication of untreated OPC is extension of infection into the esophagus. Although numerous antifungal agents are available, the azoles - both topical (clotrimazole) and systemic (fluconazole, itraconazole, posaconazole) - have replaced older topical antifungals in the management of OPC. Fluconazole has become an integral part of the management of mucosal candidiasis. Itraconazole and posaconazole have clinical response rates similar to those of fluconazole and are effective alternatives.

KW - Antifungal agents

KW - Azoles

KW - Oropharyngeal candidiasis

UR - http://www.scopus.com/inward/record.url?scp=39749160358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39749160358&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:39749160358

VL - 24

SP - 427

EP - 436

JO - Infections in Medicine

JF - Infections in Medicine

SN - 0749-6524

IS - 10

ER -